In a report, researchers discussed the evolving role of noninvasive tests (NITs) in assessing liver fibrosis in chronic hepatitis C (HCV) patients, particularly in the context of direct-acting antiviral (DAA) treatments.

Read More > https://hepatitisc.pocn.com/diagnosis/report-highlights-shift-to-noninvasive-tests-for-liver-fibrosis-assessment-in-patients-with-hcv-amid-daa-treatments/